October 2022 Discovery and In Vivo Evaluation of ACT-660602: A Potent and Selective Antagonist of the Autoimmune Diseases "The chemokine receptor CXCR3 is a seven-transmembrane G-protein-coupled receptor (GPCR high-throughput screening hit, we describe the iterative optimization of a chemical series culminating in the discovery Read more at the source #DrGPCR #GPCR #IndustryNews

Read more at the source #DrGPCR #GPCR #IndustryNews

Drug discovery often assumes receptor inhibition follows simple rules—agonist binds, antagonist blocks That paper quantified how one drug could block another’s access to a receptor—a framework that Heinz The Quick Glance: pA₂ as Shortcut Sometimes, discovery projects don’t have the luxury of full curve analyses Built for pharmacologists refining tools, discovery teams solving bottlenecks, and leaders seeking credible GPCR innovation is accelerating—those who act now will define tomorrow’s breakthroughs.

August 2022 RAB-Symposium - Regulatory Autoantibodies Targeting GPCRs. September 15-16, 2022. GPCRs are involved in a variety of physiological and pathophysiological processes. So far, numerous therapeutics targeting GPCRs have been developed, with a focus on small molecules and Recently, functional autoantibodies targeting GPCRs have been associated with various disease-specific Read more at the source #DrGPCR #GPCR #IndustryNews

Function and structure of bradykinin receptor 2 for drug discovery. discovery platform Antiverse identifies therapeutic antibodies targeting GPCRs CEO Andrew Hopkins on Exscientias AI-Driven Approach to Modern Drug Discovery Arcoscreen will present in the start-up village Progressive Technologies and Approaches Revealing Novel GPCR Biology and Drug Development Potential. Computational drug design postdoc at the Department of Drug Design and Pharmacology.

Read more at the source #DrGPCR #GPCR #IndustryNews Subscribe to the Dr. GPCR Newsletter HERE

Ingelheim take first steps towards collaborating to unlock orphan targets leveraging InterAx AI driven discovery accelerate and improve the prediction of first-in-class small molecule agonists for a challenging orphan GPCR for a highly relevant therapeutic need. 💊 InterAx Biotech AG discovery platform was already successfully #ai #biotech #systemsbiology #drugdiscovery #gpcr #deeptech #orphandrugs #pharma #partnerships #AI4drugdiscovery " Read more at the source #DrGPCR #GPCR #IndustryNews

lipids have been shown to stabilize an active conformation of class A G-protein coupled receptors (GPCRs ) through a conserved binding site, not present in class B GPCRs. For class B GPCRs, previous molecular dynamics (MD) simulation studies have shown PI(4,5)P2 interacting conformation of GCGR through a binding site conserved across class B GPCRs but absent in class A GPCRs Read more at the source #DrGPCR #GPCR #IndustryNews

GPCR Binders, Drugs, and more Predicting allosteric sites using fast conformational sampling as guided Methods & Updates in GPCR Research Discovery and design of G protein-coupled receptor targeting antibodies Investigating the potential of GalR2 as a drug target for neuropathic pain. Progressive Technologies and Approaches Revealing Novel GPCR Biology and Drug Development Potential. GPCR Ecosystem

describe production of the human A2A adenosine receptor (A2AAR), a class A G protein-coupled receptor (GPCR Read more at the source #DrGPCR #GPCR #IndustryNews

Recently, several GPCRs have been found to play important roles in the cochlea. Frizzleds and Lgrs are dominant GPCRs that regulate stem cell self-renew abilities. And A1, A2A, and CB2 activation by agonists has protective functions on noise- or drug-induced hearing Here, we review the key findings of GPCR in the cochlea and discuss the role of GPCR in the cochlea, Read more at the source #DrGPCR #GPCR #IndustryNews Subscribe to the Dr. GPCR Newsletter

However, the drug development of CX3CR1 is hampered partially by the lack of structural information. A much smaller conformational change of helix VI upon activation than previously solved class A GPCR-Gi Thus, our data deepen the understanding of cholesterol modulation in GPCR (G protein-coupled receptor Read more at the source #DrGPCR #GPCR #IndustryNews

sweet taste receptor is a heterodimeric receptor composed of two distinct G-protein-coupled receptors (GPCRs The TAS1R2 and TAS1R3 subunits are members of a small family of class C GPCRs whose members share the Read more at the source #DrGPCR #GPCR #IndustryNews

We previously demonstrated that the G protein-coupled receptor (GPCR) arginine vasopressin receptor type1A AVPR1A is part of a family of GPCR's including arginine vasopressin receptor type 2 (AVPR2). Read more at the source #DrGPCR #GPCR #IndustryNews

August 2022 "GPCRs in Medicinal Chemistry Event 8th RSC / SCI symposium on GPCRs in Medicinal Chemistry 6th September 30th September – online registration (card payments)" Read more at the source #DrGPCR #GPCR

October 2022 "Arrestins interact with G protein-coupled receptors (GPCRs) to stop G protein activation Recent structural studies shed light on the molecular mechanisms involved in GPCR-arrestin coupling, but whether this process is conserved among GPCRs is poorly understood. It reveals an atypical position of β-arrestin1 compared to previously described GPCR-arrestin assemblies Read more at the source #DrGPCR #GPCR #IndustryNews

components of the intracellular signaling pathways that mediate the effects of G protein-coupled receptors (GPCRs Upon activation, GPCRs have conformational changes that allow the coupling and subsequent activation Role of RGS proteins in regulating GPCR signaling: Recent studies have revealed that the interaction The interaction between RGS proteins and GPCRs is highly specific and tightly regulated; mutations in and amplitude of GPCR signaling.

GPCR Virtual Cafe? Join us for another virtual cafe talk to hear about the amazing work that Dr. Simone Promel / Promel Lab is doing on adhesion #GPCRs. Register here (free): https://www.ecosystem.drgpcr.com/dr-gpcr-virtual-cafe/ #gpcr #drgpcr #podcast

helps in elucidating the metabolic pathways involved in metabolic dysfunction and in developing new drugs Read more at the source #DrGPCR #GPCR #IndustryNews

Read more at the source #DrGPCR #GPCR #IndustryNews

Emerging evidence suggests adenosine G protein-coupled receptors (GPCRs) are promising therapeutic targets into some novel strategies, including allosterism and the targeting of oligomers, which may increase drug discovery success and enhance the therapeutic response." Read more at the source #DrGPCR #GPCR #IndustryNews

Biosensors to Study Conformational Dynamics and Signaling in Drug Discovery 🚨 LAST CHANCE! GPCR Event Spotlight Discovery on Target’s 19th Annual GPCR-Based Drug Discovery Targeting G Protein-Coupled Register now for the GPCR Drug Discovery Conference and unlock incredible savings of $200 using the 26 - 28, 2024 | GPCRs-Targeted Drug Discovery Summit Europe July 12 - 17, 2026 | 20th World Congress Dynamics and Signaling in Drug Discovery Flavors of GPCR signaling bias Glucagon-like peptide-1 receptor

cost-effective methodologies for screening compound libraries targeting the CBRs becomes key for identifying drugs It has been applied to different GPCR binding assays, such as CXCR4, opioid receptors, CCK1 and CCK2. Cannabinoids as Anticancer Drugs: Current Status of Preclinical Research. HTRF: A Technology Tailored for Drug Discovery - A Review of Theoretical Aspects and Recent Applications SLAS Discovery   2010 , 15 (10), 1248–1259. https://doi.org/10.1177/1087057110384611 . (25)      Fulp

Emerging evidence suggests adenosine G protein-coupled receptors (GPCRs) are promising therapeutic targets into some novel strategies, including allosterism and the targeting of oligomers, which may increase drug discovery success and enhance the therapeutic response." Read more at the source #DrGPCR #GPCR #IndustryNews

Don’t miss out on insightful resources like '   Applying Pharmacology to Drug Discovery ' and ' Advanced discovery strategies. agonist-producing Bacillus velezensis ADS024 is efficacious in multiple neuroinflammatory disease models Discovery Discovery GPCR Events, Meetings, and Webinars September 5 - 6, 2024 | 4th Transatlantic ECI GPCR Symposium September 18, 2024 | FREE Webinar - The value of GPCR cell-based assays in drug discovery October 2024

October 2022 "Recently determined structures of class C G protein-coupled receptors (GPCRs) revealed the location of allosteric binding sites and opened new opportunities for the discovery of novel modulators treatment of psychiatric and neurodegenerative diseases, and several allosteric modulators of this GPCR in complex with allosteric modulators can accelerate lead discovery." Read more at the source #DrGPCR #GPCR #IndustryNews

orphan and constitutively active receptor belonging to the superfamily of G-Protein Coupled Receptors (GPCRs Read more at the source #DrGPCR #GPCR #IndustryNews

Understanding receptor-ligand interaction is key in drug discovery and biomedical research. Radioligands have been used to study GPCRs for decades, but with the advances in the fluorescence field This can be done with agonists, antagonists, reverse agonists in the case of GPCRs. Figure 1. GPCR-radioligand binding assays. Fluorescent ligands: Bringing light to emerging GPCR paradigms.

Therefore, mGluR2 and mGluR3 have been considered as potential drug targets for the treatment of many Alzheimer's disease, Huntington's disease, Parkinson's diseases, schizophrenia and depression as well as drug We then highlight the evidence supporting the use of various drugs including orthosteric and allosteric Read more at the source #DrGPCR #GPCR #IndustryNews

scoring protective hits included the complement C3a receptor (C3aR), a G-protein coupled receptor (GPCR Read more at the source #DrGPCR #GPCR #IndustryNews